Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches
Authors
Keywords
-
Journal
Gastroenterology Research and Practice
Volume 2018, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2018-12-19
DOI
10.1155/2018/7530619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer
- (2018) Christopher J. Halbrook et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC)
- (2018) Tao Lianyuan et al. CANCER BIOLOGY & THERAPY
- HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma
- (2018) Sunil R. Hingorani et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
- (2018) David Linehan et al. JOURNAL OF CLINICAL ONCOLOGY
- A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection
- (2018) Nicholas G. Mowbray et al. HPB
- Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
- (2018) Jiajia Zhang et al. Cancers
- Association of TGF-β responsive signature with anti-tumor effect of vactosertib, a potent, oral TGF-β receptor type I (TGFBRI) inhibitor in patients with advanced solid tumors.
- (2018) Vicki Leigh Keedy et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase Ib/II study of lacnotuzumab (MCS110) combined with spartalizumab (PDR001) in patients (pts) with advanced tumors.
- (2018) Aitana Calvo et al. JOURNAL OF CLINICAL ONCOLOGY
- Potentially curative combination of TGF-b1 inhibitor losartan and FOLFIRINOX (FFX) for locally advanced pancreatic cancer (LAPC): R0 resection rates and preliminary survival data from a prospective phase II study.
- (2018) Janet E. Murphy et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of anti-CTGF human recombinant monoclonal antibody pamrevlumab on resectability and resection rate when combined with gemcitabine/nab-paclitaxel in phase 1/2 clinical study for the treatment of locally advanced pancreatic cancer patients.
- (2018) Vincent J. Picozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).
- (2018) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II pilot trial of nivolumab + albumin bound paclitaxel + paricalcitol + cisplatin + gemcitabine (NAPPCG) in patients (pts) with previously untreated metastatic pancreatic ductal adenocarcinoma.
- (2017) Erkut Hasan Borazanci et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of cytotoxic tumor-infiltrating T lymphocytes on outcome in resectable pancreatic cancer: Results from the CONKO 001 trial.
- (2017) Jana Kaethe Striefler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) ± gemcitabine (Gem) in solid tumors: Interim results from the pancreatic cancer (PC) cohorts.
- (2017) Zev A. Wainberg et al. JOURNAL OF CLINICAL ONCOLOGY
- The pancreatic cancer microenvironment: A true double agent
- (2017) Laleh G. Melstrom et al. JOURNAL OF SURGICAL ONCOLOGY
- Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
- (2017) Patricia Dauer et al. PANCREATOLOGY
- Pancreatic stellate cell: Pandora's box for pancreatic disease biology
- (2017) Ratnakar R Bynigeri et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
- (2017) Guido Giordano et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20)
- (2017) Kit Man Wong et al. Current Oncology Reports
- Cancer associated fibroblasts: An essential role in the tumor microenvironment
- (2017) Leilei Tao et al. Oncology Letters
- Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
- (2017) Srinivasa P. Pothula et al. Oncotarget
- Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
- (2017) Jung-Eun Jang et al. Cell Reports
- Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
- (2017) Shuai Wang et al. Biomed Research International
- Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
- (2017) Jennifer Peyling Wang et al. Journal of Cancer
- Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT).
- (2017) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- More deaths from pancreatic cancer than breast cancer in the EU by 2017
- (2016) J. Ferlay et al. ACTA ONCOLOGICA
- Macrophages and pancreatic ductal adenocarcinoma
- (2016) Aida Habtezion et al. CANCER LETTERS
- Tumor angiogenesis—characteristics of tumor endothelial cells
- (2016) Kyoko Hida et al. International Journal of Clinical Oncology
- Role of immune cells in pancreatic cancer from bench to clinical application
- (2016) Jae Hyuck Chang et al. MEDICINE
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
- (2016) Daniel Delitto et al. PHARMACOLOGY & THERAPEUTICS
- Pericyte–fibroblast transition promotes tumor growth and metastasis
- (2016) Kayoko Hosaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer
- (2016) Hai Hu et al. TUMOR BIOLOGY
- Prognostic value of PDL1 expression in pancreatic cancer
- (2016) David J. Birnbaum et al. Oncotarget
- Role of microenvironmental periostin in pancreatic cancer progression
- (2016) Yang Liu et al. Oncotarget
- Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer
- (2016) Jinhoi Song et al. Oncotarget
- Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma
- (2016) Angela Diana et al. Oncotarget
- The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival
- (2015) Daniel Delitto et al. BMC CANCER
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
- (2015) M. Hidalgo et al. CLINICAL CANCER RESEARCH
- Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment
- (2015) Esak Lee et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer
- (2015) J. Tabernero et al. ONCOLOGIST
- Pancreatic cancer: The microenvironment needs attention too!
- (2015) M.V. Apte et al. PANCREATOLOGY
- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
- (2015) Y. Pylayeva-Gupta et al. Cancer Discovery
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- The role of hypoxia in pancreatic cancer: a potential therapeutic target?
- (2015) Mert Erkan et al. Expert Review of Gastroenterology & Hepatology
- Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways
- (2014) Fabienne Guillaumond et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Target Therapies in Pancreatic Carcinoma
- (2014) Nicola Silvestris et al. CURRENT MEDICINAL CHEMISTRY
- Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies
- (2014) Jonathan Haqq et al. EUROPEAN JOURNAL OF CANCER
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis
- (2014) Long-Yun Ye et al. PANCREATOLOGY
- Hyaluronan, fluid pressure and stromal resistance in pancreas cancer
- (2013) P P Provenzano et al. BRITISH JOURNAL OF CANCER
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Mucins in pancreatic cancer and its microenvironment
- (2013) Sukhwinder Kaur et al. Nature Reviews Gastroenterology & Hepatology
- Contribution of bone marrow derived cells to the pancreatic tumor microenvironment
- (2013) Christopher J. Scarlett Frontiers in Physiology
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors
- (2012) Matthias M. Gaida et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bone marrow-derived proangiogenic cells in pancreatic cancer
- (2012) Yusuke Mizukami JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Dangerous liaisons: Pancreatic stellate cells and pancreatic cancer cells
- (2012) Minoti V Apte et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
- (2012) Mert Erkan et al. Nature Reviews Gastroenterology & Hepatology
- Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma
- (2011) Dirk Bausch et al. ANGIOGENESIS
- Tumor-infiltrating neutrophils in pancreatic neoplasia
- (2011) Michelle D Reid et al. MODERN PATHOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction
- (2011) Christopher J. Scarlett et al. PLoS One
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells
- (2010) Kazuhiro Kikuta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of fibroblasts in cancer stroma
- (2010) Kati Räsänen et al. EXPERIMENTAL CELL RESEARCH
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Organotypic Culture Model of Pancreatic Cancer Demonstrates that Stromal Cells Modulate E-Cadherin, β-Catenin, and Ezrin Expression in Tumor Cells
- (2009) Fieke E.M. Froeling et al. AMERICAN JOURNAL OF PATHOLOGY
- Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture
- (2009) Isao Kii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
- (2009) Hiroshi Kurahara et al. JOURNAL OF SURGICAL RESEARCH
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Role of TGF- β in the Tumor Stroma
- (2008) H. Naber et al. CURRENT CANCER DRUG TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now